Article

FDA Approves Herceptin Biosimilar for Breast Cancer Treatment

The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer.

The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer.

Common expected adverse effects of Herzuma include headache, diarrhea, nausea, chills, fever, infection, congestive heart failure, insomnia, cough and rash. Serious expected adverse effects of Herzuma include worsening of chemotherapy-induced neutropenia.

Like Herceptin, the labeling for Herzuma contains a Boxed Warning to alert health care professionals and patients about increased risks of cardiomyopathy, infusion reactions, pulmonary toxicity and embryo-fetal toxicity.

This article originally appeared on Specialty Pharmacy Times as "FDA Approves Herceptin Biosimilar Treatment of HER2-overexpressing Breast Cancer."

Related Videos
Image of woman with blonde hair.
Image of woman with brown hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a woman wearing a red tank top.
Image of Annie Bond.
Image of a man with rectangular glasses and short dark hair.
Image of a woman with long dark hair.
Related Content
Image of woman holding ribbon.
November 21st 2024

Aerobic Exercise May Improve Self-Reported Cognitive Function in Breast Cancer

Spencer Feldman
Aerobic exercise improved self-reported cognitive function in women undergoing chemotherapy for breast cancer but had no effect on objective cognitive function.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of COVID-19 cells.
November 18th 2024

COVID-19 RNA May Be Linked to Metastatic Cancer Regression

Ashley Chan
RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more research is necessary.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of a person's pancreas, indicating cancer.
November 15th 2024

Quincy Jones Died of Cancer, Dwayne Johnson Connects with a Fan with Cancer and More

Alex Biese
From producer Quincy Jones’ death from pancreatic cancer to an inspiring moment between The Rock and a fan at a store, here’s what’s happening in the cancer space this week.
Woman putting on compression stockings on swollen feet affected by lymphedema condition: © Julia - stock.adobe.com
November 13th 2024

Lymphedema Myths and Misconceptions, From Exercise to Blood Draws

Alex Biese
An expert explains how attitudes towards lymphedema risk have evolved over the years.